State Ledger
Company profile

OMEROS CORP CIK 1285819

Ticker
OMER (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Seattle, WA 98119
Fiscal year end
2025 (FY)
Market Data
Close
$19.83
Change
+$0.71
Change %
3.69%
Volume
58,011

OMER · trading date Oct 9, 2026 · previous close $19.12 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$3.35M
Total assets
$325.63M
Total liabilities
—
Stockholders' equity
-$121.23M
Cash & equivalents
$9.66M
Operating income
-$122.80M
Operating cash flow
-$116.09M
Capital expenditures
$65.0K

Fiscal year 2025, via 10-K filed 2026-03-31. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$116.16M
Free cash flow margin
—
Liabilities / assets
—
Equity / assets
-37.2%
CapEx / revenue
—
Operating cash flow / net income
34.65×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$3.35M $325.63M — -$121.23M
2024 — -$156.82M $277.08M — -$182.61M
2023 — -$117.81M $378.27M — -$24.98M
2022 — $47.42M $590.97M — $85.68M
2021 — $194.24M $419.27M — $23.78M
Company Details
SIC code
2834
State of incorporation
WA
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-01
Financials filed via
Form 10-K
filed 2026-03-31

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Seattle, WA 98119
201 ELLIOTT AVENUE WEST
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:01 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Washington — Public Companies